Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective

The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as he...

Descripción completa

Detalles Bibliográficos
Autores principales: Teh, Jiasian, O’Connor, Ellen, Coles-Black, Jasamine, Lawrentschuk, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471589/
https://www.ncbi.nlm.nih.gov/pubmed/32886143
http://dx.doi.org/10.1007/s00345-020-03416-4
_version_ 1783578800161816576
author Teh, Jiasian
O’Connor, Ellen
Coles-Black, Jasamine
Lawrentschuk, Nathan
author_facet Teh, Jiasian
O’Connor, Ellen
Coles-Black, Jasamine
Lawrentschuk, Nathan
author_sort Teh, Jiasian
collection PubMed
description The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology.
format Online
Article
Text
id pubmed-7471589
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74715892020-09-04 Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective Teh, Jiasian O’Connor, Ellen Coles-Black, Jasamine Lawrentschuk, Nathan World J Urol Topic Paper The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. Springer Berlin Heidelberg 2020-09-04 2021 /pmc/articles/PMC7471589/ /pubmed/32886143 http://dx.doi.org/10.1007/s00345-020-03416-4 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Topic Paper
Teh, Jiasian
O’Connor, Ellen
Coles-Black, Jasamine
Lawrentschuk, Nathan
Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title_full Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title_fullStr Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title_full_unstemmed Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title_short Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
title_sort clinical trials in urological oncology: covid-19 and the potential need for a new perspective
topic Topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471589/
https://www.ncbi.nlm.nih.gov/pubmed/32886143
http://dx.doi.org/10.1007/s00345-020-03416-4
work_keys_str_mv AT tehjiasian clinicaltrialsinurologicaloncologycovid19andthepotentialneedforanewperspective
AT oconnorellen clinicaltrialsinurologicaloncologycovid19andthepotentialneedforanewperspective
AT colesblackjasamine clinicaltrialsinurologicaloncologycovid19andthepotentialneedforanewperspective
AT lawrentschuknathan clinicaltrialsinurologicaloncologycovid19andthepotentialneedforanewperspective

Ejemplares similares